HCRT and obesity due to melanocortin 4 receptor deficiency: The significance of their tangential impacts uncovered the fact that the orexin system has great potential as the therapeutic agent for a broad array of human diseases across the spectrum, from narcolepsy to digestive cancers to obesity.